Caitong International Asset Management Co., LTD Madrigal Pharmaceuticals, Inc. Transaction History
Caitong International Asset Management Co., LTD
- $102 Billion
- Q4 2024
A detailed history of Caitong International Asset Management Co., LTD transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 106 shares of MDGL stock, worth $37,209. This represents 0.03% of its overall portfolio holdings.
Number of Shares
106
Previous 106
-0.0%
Holding current value
$37,209
Previous $32.7 Million
-0.0%
% of portfolio
0.03%
Previous 0.03%
Shares
1 transactions
Others Institutions Holding MDGL
# of Institutions
335Shares Held
22.3MCall Options Held
960KPut Options Held
940K-
Janus Henderson Group PLC London, X02.21MShares$775 Million0.36% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.04MShares$717 Million38.14% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.03MShares$712 Million9.12% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$700 Million10.03% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$693 Million6.75% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $6B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...